Skip to main content
Incyte10-Q: Restructuring

New CFO Suketu Upadhyay appointed effective May 4, 2026, with $5M+ compensation package.

What happened

Mr.

Source

SEC EDGARApr 28, 2026

Quarterly report (Form 10-Q)

Incyte 10-Q

Filing excerpt

On April 28, 2026, the Company announced that it has appointed Suketu Upadhyay as Executive Vice President and Chief Financial Officer of the Company, effective as of May 4, 2026.

sec.gov/Archives/edgar/data/879169/000087916926000026/incy-20260331.htmRead the full source

Other signals in this filing (10)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
03/31
Filed
Apr 28, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$5.8M (New CFO's first-year target compensation package, including $5M in equity grants, $500k signing bonus, and $850k base salary.)

Details

CIK
879169
Accession number
0000879169-26-000026
Timeframe
Current year
Filing year
2026
Fiscal year
0
Why it matters
Change management needs
Signal category
Workforce

Topics and mentions

Vendors

  • KPMG
  • CSC (Corporate Services Company)

Competitors

  • Zimmer Biomet
  • Bristol Myers Squibb
  • Endo International
  • AstraZeneca
  • Johnson & Johnson
  • Vertex Pharmaceuticals

Extraction

Confidence
High
Relevance
100%
Sentiment
Positive
Detected
May 5, 2026
signal_type
sec-10q
signal_subtype
restructuring

Use this data

Get every 10-Q signal for Incyte and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Incyte this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4c92683c-389a-4052-b8a6-7b3ade96492e returns this record as JSON. POST /v1/companies/enrich returns every signal for incyte.com.

{
  "signal_id": "4c92683c-389a-4052-b8a6-7b3ade96492e",
  "signal_type": "sec-10q",
  "signal_subtype": "restructuring",
  "detected_at": "2026-05-05T08:48:22.627+00:00",
  "company": {
    "name": "Incyte",
    "domain": "incyte.com"
  },
  "data": {
    "detail": "The appointment of a new EVP and Chief Financial Officer often triggers a 90-day review of financial systems, vendor contracts, and operational spending. Mr. Upadhyay's background in finance, operations, and supply chain suggests a comprehensive evaluation is likely, creating opportunities for new solutions.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "New CFO's first-year target compensation package, including $5M in equity grants, $500k signing bonus, and $850k base salary.",
      "dollar_millions": 5.85
    },
    "summary": "New CFO Suketu Upadhyay appointed effective May 4, 2026, with $5M+ compensation package.",
    "excerpts": "On April 28, 2026, the Company announced that it has appointed Suketu Upadhyay as Executive Vice President and Chief Financial Officer of the Company, effective as of May 4, 2026.",
    "relevance": 1,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/879169/000087916926000026/incy-20260331.htm",
    "filing_date": "2026-04-28",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce",
    "vendors_mentioned": [
      "KPMG",
      "CSC (Corporate Services Company)"
    ],
    "competitors_mentioned": [
      "Zimmer Biomet",
      "Bristol Myers Squibb",
      "Endo International",
      "AstraZeneca",
      "Johnson & Johnson",
      "Vertex Pharmaceuticals"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.